EVALUATING THE PHOTODYNAMIC AND SONODYNAMIC POTENTIAL OF CLINICALLY RELEVANT PHOTOSENSITIZERS AND DYES

Abstract

Light-activable agents such as fluorophores and photosensitizers are used for fluorescenceimaging and photodynamic therapy (PDT) applications in the clinic. These agents can absorb light at specific wavelengths and generate fluorescence and/or cytotoxic reactive molecular species (RMS). Photosensitizers can also interact with ATP-binding cassette (ABC) transporters on target cells. This interaction can affect the intracellular accumulation of photosensitizers and thereby influence imaging and treatment efficacy and outcomes. Currently, there are no well-established methods for screening photoactive agents for potential phototoxicity, creating a need for reliable iii testing methods. Comprehensive screening methods are essential for ensuring safe and effective imaging and therapeutic outcomes with light activable agents. Moreover, photosensitizers are currently being explored for sonodynamic therapy (SDT) with ultrasound in patients. Just like PDT, photosensitizers are thought to be activated by ultrasound-mediated light generation (sonoluminescence) to generate RMS. However, no evidence supporting this mechanism has been published with safe, monitorable, and reproducible SDT effects. Thus, rigorous test methods must be developed to evaluate photochemical activation of photosensitizers using clinically relevant SDT parameters. The results obtained through the studies in this dissertation resulted in (1) A modified invitro test method for assessing the photo-cytotoxic potential of light-activable agents at clinically relevant concentrations and illumination parameters, (2) Updated the ABC transporter substrate status of clinically relevant using in-vitro extraction and flowcytometry methods. (3) Confirmed lack of photochemical activation of clinically relevant photosensitizers during SDT as a potential mechanism of action using a phantom model. A comprehensive understanding of the mechanisms and factors affecting the safety and efficacy of fluorophores and photosensitizers is essential for advancing the field of fluorescence imaging, PDT, and SDT for cancer and other diseases.